Key takeaway: DCW Limited submitted its investor presentation for the quarter ended June 30, 2026, highlighting a 14% year-on-year growth in revenue from operations, reaching INR 5,419 million. The presentation reported a significant increase in the Specialty Chemicals segment, which grew by 38%, while Basic Chemicals saw a 5% growth. EBITDA was reported at INR 358 million, reflecting a decline of 33.3% year-on-year, with EBITDA margins at 6.61%. The company noted challenges due to VCM availability and elevated prices impacting profitability. Management indicated that net leverage improved, with a goal to turn net cash positive by the end of FY27. The presentation also outlined planned capital expenditures for expanding SIOP capacity and improving power plant efficiency, with a total investment estimated at INR 250 crore over the next 2-3 years.

Key takeaway: DCW Limited held its Q4 FY26 Earnings Conference Call on May 6, 2026, where management discussed the company's performance amidst a challenging global chemical industry environment. Management reported an 11% year-on-year growth in EBITDA and over 60% growth in PAT, despite declining net realizations across most product lines. The company achieved record sales volumes in C-PVC, synthetic iron oxide pigment, and synthetic rutile. Management highlighted the successful expansion of C-PVC capacity and the commissioning of a renewable energy project, which contributed to cost savings. The CFO provided detailed financial metrics, noting a 13.2% increase in Q4 revenue and a reduction in finance costs. Management acknowledged ongoing pressures from imports and geopolitical factors affecting pricing but expressed confidence in the company's operational efficiencies and future growth potential. The call concluded with a Q&A session addressing various market dynamics and company strategies.

Key takeaway: DCW Limited submitted its investor presentation for the quarter and financial year ended March 31, 2026, to BSE and NSE. The presentation highlighted a 5-year CAGR of 66% in PAT and 8% in revenue, with specialty chemicals contributing 28% to revenue. The company reported a 13.2% year-on-year increase in Q4 revenue, reaching INR 6,091 million, and a 7.2% increase for FY26, totaling INR 21,436 million. EBITDA for Q4 was INR 646 million, reflecting a 16% increase, while PAT rose by 60.2% to INR 181 million. The company maintained a low net debt to equity ratio of 0.07 and a net debt to EBITDA ratio of 0.32. Management noted the highest-ever sales volumes in CPVC, SIOP, and Synthetic Rutile during the year, despite challenges in the PVC segment due to captive consumption.

Key takeaway: DCW Limited held its Q3 FY26 earnings conference call on February 11, 2026, where management discussed the company's performance amid a challenging global chemical industry environment. Management reported a 10% year-on-year revenue growth, driven by strong volume momentum and contributions from Specialty Chemicals, despite price erosion across product segments. The Basic Chemicals segment faced operating pressure, particularly in PVC, while the Specialty Chemicals segment showed robust growth, particularly in CPVC and Synthetic Iron Oxide Pigment. Management highlighted ongoing investments in capacity expansion and digital integration, aiming for a more resilient and scalable business model. The company reported an EBITDA of INR 50 crores for the quarter, down 19% year-on-year, and a net profit before tax of INR 7.5 crores. Management noted a focus on reducing debt and enhancing operational efficiencies, with plans for further growth in the Specialty Chemicals segment.

Key takeaway: DCW Limited submitted its investor presentation for the third quarter and nine months ended December 31, 2025, to the National Stock Exchange of India and BSE Limited. The presentation highlighted a 9.6% year-on-year increase in operational revenue to INR 5,198 million for Q3-FY26, despite price erosion across product segments. EBITDA for the quarter was reported at INR 452 million, reflecting a 20.6% decline year-on-year, with EBITDA margins at 8.70%. For the nine-month period, revenue reached INR 15,345 million, a 4.9% increase, while EBITDA increased by 14.1% to INR 1,570 million. The company noted significant volume growth in its specialty chemicals segment, particularly in Synthetic Iron Oxide Pigments (SIOP) and Chlorinated Poly Vinyl Chloride (C-PVC). However, basic chemicals faced challenges due to price erosion without a corresponding reduction in input costs. The presentation also detailed the company's strategic focus on specialty chemicals and ongoing capital expenditure plans.